Bleeding during abdominal myomectomy. Leiomyoma of uterus
Conditions
Interventions
Intervention 1: In the study group (n=40) oxytocin 30 u into 1000 ml normal saline will be infused during myomectomy. Intervention 2: In the placebo group (n=40) normal saline alone 1000 ml will b
Treatment - Drugs
In the study group (n=40) oxytocin 30 u into 1000 ml normal saline will be infused during myomectomy.
In the placebo group (n=40) normal saline alone 1000 ml will be infused during myomectomy.
Sponsors
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 60 Years
Inclusion criteria
Inclusion criteria: Including criteria: Women undergoing abdominal myomectomy; over 35 years age Excluding criteria: Patients candidate for hysteroscopic myomectomy; Patients with preoperative GnRH agonist consumption; Patients with history of cardiopulmonary disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of bleeding. Timepoint: During myomectomy. Method of measurement: Count sponges and the amount of blood collected in the suction device - according to ml. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of blood transfusion. Timepoint: Intra and postoperative. Method of measurement: Observation, Physical examination- Blood unit according to ml.;Hb and HcT values. Timepoint: Prior to operation and 24 h after operation. Method of measurement: Elyza method-CBC[ Hb(g/dl), HcT(%)}. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Simin Atashkhoei
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Outcome results
None listed